American legislators are frustrated by high drug prices. In addition to financial distress from medication payments, some patients resort to modifying their medication dosages. Now, both Democrats and Republican around the country are sponsoring bills to limit these drug prices, rather than waiting for Congress. A recent report from ICER noted numerous unjustified price increases. Pharmaceutical companies strongly oppose pricing regulation policies. Humira manufacturer AbbVie has been criticized for its patent monopoly.
According to senator and former medical doctor Ned Claxton of Maine, “I’m not looking to gather more tax dollars,” adding, “The best outcome would be to have drug companies just sell at a lower price.” Read more here.
(Source: Harris Meyer, KHN, 2/12/21)